Do you substitute inhaled amikacin for intravenous amikacin in addition to the triple regimen of macrolide + ethambutol + rifampin for cavitary lung disease secondary to Mycobacterium malmoense?

This is a rare organism and I have not had to deal with anyone with this infection so I will approach this question as a general NTM question. Since there is no or very limited data on the use of liposomal amikacin inhalation form for people who are starting NTM treatment, my recommendation would be...